At The Royal Marsden, they deal with cancer every day so they understand how valuable life is. And when people entrust their lives to them, they have the right to demand the very best.
The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education.
Today, together with its academic partner, The Institute of Cancer Research (ICR), The Royal Marsden is the largest and most comprehensive cancer centre in Europe, treating over 50,000 NHS and private patients every year. It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies, as well as specialising in cancer diagnosis and education.
The Royal Marsden, with the ICR, is the only National Institute for Health Research Biomedical Research Centre dedicated solely to cancer. First awarded the status in 2006, it was re-awarded in 2011. £62 million is provided over five years to be shared across eight different cancer themes.
They have two hospitals: one in Chelsea, London, and another in Sutton, Surrey. They also have a Medical Daycare Unit at Kingston Hospital. The Royal Marsden also provides community services in the London borough of Sutton and in June 2010, along with the ICR, The Royal Marsden launched an academic partnership with Mount Vernon Cancer Centre in Middlesex.
Since 2004, supporters of the hospital's charity, The Royal Marsden Cancer Charity, have helped raise over £100 million to build theatres, diagnostic centres and drug development units.
HRH The Duke of Cambridge became President of The Royal Marsden in 2007, following a long royal connection with the hospital.
Their mission is to continue to make a national and global contribution to cancer research and treatment, so that more people are cured and quality of life is improved for those living with cancer